Alnylam Pharmaceuticals
ALNY
#690
Rank
ยฃ28.03 B
Marketcap
ยฃ210.00
Share price
-1.99%
Change (1 day)
-7.74%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company